Major Depression: Clinical Trials

4 trials for Major Depression, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Terminated 4
Phase 31Terminated 1

Follow Major Depression: new trials by email Literature Review of Major Depression trials Research Report on Major Depression

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Omega 3 FA Supplements as Augmentation in the Treatment of Depression
Desvenlafaxine, Omega 3 Fatty acids, Placebo (for Omega 3 fatty acid supplement) - Major Depression, Cancer
Phase 2 / Phase 3TerminatedUConn Health62013-02-012017-12-27
Study of Depression-Ketamine-Brain Function
Ketamine - Major Depression
Phase 2TerminatedMarkus KOSEL102010-06-012015-12-07
Family Based Treatment of Depressed Adolescents
Attachment Based Family therapy (ABFT) - Depressive Disorder, Mood Disorder
Phase 2TerminatedHelse Stavanger HF202008-06-012015-07-31
Fluoxetine Versus Fluoxetine Plus DU125530 in Major Depressive Disorder
DU125530, Placebo - Major Depression
Phase 2TerminatedFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau502004-05-012010-05-07

Narrower conditions

Depressive Disorder, Major (4)  ·  Depression (3)  ·  Cardiovascular Diseases (1)  ·  Depressive Disorder (1)  ·  Diabetes Mellitus (1)  ·  Hypertension (1)  ·  Mood Disorders (1)  ·  Neoplasms (1)

Broader conditions

Mental Disorders (4)  ·  Behavior (3)  ·  Behavioral Symptoms (3)  ·  Depressive Disorder (3)  ·  Mood Disorders (3)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Vascular Diseases (1)

Interventions

1,2-benzisothiazol-3(2H)-one, 2-(4-(4-(7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)-1-piperazinyl)butyl)-, 1,1-dioxide (1)  ·  Desvenlafaxine Succinate (1)  ·  Fatty Acids, Omega-3 (1)  ·  Ketamine (1)

Sponsors

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)  ·  Helse Stavanger HF (1)  ·  Markus KOSEL (1)  ·  UConn Health (1)

Countries

Norway (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United States (1)

Top investigators

Dolors Puigdemont, MD (1)  ·  Jayesh Kamath, MD PhD (1)  ·  Markus Kosel, MD-PhD (1)  ·  Pravin Israel, Ph.D (1)

Results publications

PMID 22050051